Titre : Hémizygote

Hémizygote : Questions médicales fréquentes

Termes MeSH sélectionnés :

Multifactorial Inheritance
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Hémizygote : Questions médicales les plus fréquentes", "headline": "Hémizygote : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Hémizygote : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-11", "dateModified": "2025-04-06", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Hémizygote" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Génotype", "url": "https://questionsmedicales.fr/mesh/D005838", "about": { "@type": "MedicalCondition", "name": "Génotype", "code": { "@type": "MedicalCode", "code": "D005838", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.380" } } }, "about": { "@type": "MedicalCondition", "name": "Hémizygote", "alternateName": "Hemizygote", "code": { "@type": "MedicalCode", "code": "D057898", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Xiaomeng Yang", "url": "https://questionsmedicales.fr/author/Xiaomeng%20Yang", "affiliation": { "@type": "Organization", "name": "Pediatric Research Institute, Qilu Children's Hospital of Shandong University, Jinan, Shandong 250022, China." } }, { "@type": "Person", "name": "Haiyan Zhang", "url": "https://questionsmedicales.fr/author/Haiyan%20Zhang", "affiliation": { "@type": "Organization", "name": "Pediatric Research Institute, Qilu Children's Hospital of Shandong University, Jinan, Shandong 250022, China." } }, { "@type": "Person", "name": "Yue Li", "url": "https://questionsmedicales.fr/author/Yue%20Li", "affiliation": { "@type": "Organization", "name": "Pediatric Research Institute, Qilu Children's Hospital of Shandong University, Jinan, Shandong 250022, China." } }, { "@type": "Person", "name": "Jingyun Guan", "url": "https://questionsmedicales.fr/author/Jingyun%20Guan", "affiliation": { "@type": "Organization", "name": "Pediatric Research Institute, Qilu Children's Hospital of Shandong University, Jinan, Shandong 250022, China." } }, { "@type": "Person", "name": "Dong Wang", "url": "https://questionsmedicales.fr/author/Dong%20Wang", "affiliation": { "@type": "Organization", "name": "Pediatric Research Institute, Qilu Children's Hospital of Shandong University, Jinan, Shandong 250022, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "HLA-haploidentical stem cell transplantation in children with inherited bone marrow failure syndromes: A retrospective analysis on behalf of EBMT severe aplastic Anemia and pediatric diseases working parties.", "datePublished": "2024-03-18", "url": "https://questionsmedicales.fr/article/38497679", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/ajh.27293" } }, { "@type": "ScholarlyArticle", "name": "Unraveling Shared and Unique Genetic Causal Relationship Between Gut Microbiota and Four Types of Uterine-Related Diseases: Bidirectional Mendelian Inheritance Approaches to Dissect the \"Gut-Uterus Axis\".", "datePublished": "2024-10-22", "url": "https://questionsmedicales.fr/article/39447936", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.annepidem.2024.10.008" } }, { "@type": "ScholarlyArticle", "name": "γ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS).", "datePublished": "2024-07-26", "url": "https://questionsmedicales.fr/article/39074479", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/S1474-4422(24)00236-9" } }, { "@type": "ScholarlyArticle", "name": "First report of resistance in Spodoptera frugiperda (Lepidoptera: Noctuidae) to lambda-cyhalothrin from Pakistan: baseline susceptibility, selection, occurrence of cross-resistance, realized heritability, and inheritance mode of resistance.", "datePublished": "2024-06-27", "url": "https://questionsmedicales.fr/article/38936423", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1093/jee/toae132" } }, { "@type": "ScholarlyArticle", "name": "Assessment of Knowledge, Attitudes, and Practices Regarding Non-Inherited Risk Factors for Congenital Heart Disease Among Mothers in Al-Baha City, Saudi Arabia: A Cross-Sectional Study.", "datePublished": "2024-05-12", "url": "https://questionsmedicales.fr/article/38864036", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.7759/cureus.60133" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes génétiques", "item": "https://questionsmedicales.fr/mesh/D055614" }, { "@type": "ListItem", "position": 3, "name": "Génotype", "item": "https://questionsmedicales.fr/mesh/D005838" }, { "@type": "ListItem", "position": 4, "name": "Hémizygote", "item": "https://questionsmedicales.fr/mesh/D057898" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Hémizygote - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Hémizygote", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-03", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Hémizygote", "description": "Comment diagnostiquer un état hémizygote ?\nQuels tests génétiques sont utilisés ?\nL'hémizygote est-il visible sur un caryotype ?\nQuels signes cliniques peuvent indiquer un hémizygote ?\nL'hémizygote est-il associé à des maladies ?", "url": "https://questionsmedicales.fr/mesh/D057898?mesh_terms=Multifactorial+Inheritance&page=207#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Hémizygote", "description": "Quels symptômes sont associés à l'hémizygotie ?\nL'hémizygote peut-il causer des anomalies physiques ?\nY a-t-il des symptômes neurologiques liés ?\nLes symptômes varient-ils selon le sexe ?\nL'hémizygote est-il lié à des troubles mentaux ?", "url": "https://questionsmedicales.fr/mesh/D057898?mesh_terms=Multifactorial+Inheritance&page=207#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Hémizygote", "description": "Comment prévenir les maladies liées à l'hémizygotie ?\nLe conseil génétique est-il recommandé ?\nY a-t-il des tests prénataux disponibles ?\nLes vaccinations peuvent-elles aider ?\nL'éducation génétique est-elle importante ?", "url": "https://questionsmedicales.fr/mesh/D057898?mesh_terms=Multifactorial+Inheritance&page=207#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Hémizygote", "description": "Quels traitements existent pour l'hémizygotie ?\nPeut-on prévenir les effets de l'hémizygotie ?\nLes traitements sont-ils différents pour les hommes et les femmes ?\nY a-t-il des thérapies spécifiques pour l'hémophilie ?\nLes thérapies géniques sont-elles efficaces ?", "url": "https://questionsmedicales.fr/mesh/D057898?mesh_terms=Multifactorial+Inheritance&page=207#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Hémizygote", "description": "Quelles complications peuvent survenir avec l'hémizygotie ?\nL'hémizygotie peut-elle affecter la fertilité ?\nY a-t-il des risques de maladies cardiovasculaires ?\nLes complications sont-elles réversibles ?\nL'hémizygotie est-elle liée à des cancers ?", "url": "https://questionsmedicales.fr/mesh/D057898?mesh_terms=Multifactorial+Inheritance&page=207#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Hémizygote", "description": "Quels sont les facteurs de risque de l'hémizygotie ?\nL'âge parental influence-t-il le risque ?\nLes facteurs environnementaux jouent-ils un rôle ?\nY a-t-il des prédispositions raciales ?\nLes habitudes de vie influencent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D057898?mesh_terms=Multifactorial+Inheritance&page=207#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer un état hémizygote ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'analyse génétique et l'examen des chromosomes." } }, { "@type": "Question", "name": "Quels tests génétiques sont utilisés ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests comme le séquençage de l'ADN et l'hybridation in situ sont courants." } }, { "@type": "Question", "name": "L'hémizygote est-il visible sur un caryotype ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les anomalies chromosomiques peuvent indiquer un état hémizygote." } }, { "@type": "Question", "name": "Quels signes cliniques peuvent indiquer un hémizygote ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des signes peuvent inclure des traits phénotypiques spécifiques liés à des gènes X." } }, { "@type": "Question", "name": "L'hémizygote est-il associé à des maladies ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies génétiques sont liées à l'hémizygotie, comme l'hémophilie." } }, { "@type": "Question", "name": "Quels symptômes sont associés à l'hémizygotie ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes varient selon le gène affecté, incluant des troubles de la coagulation." } }, { "@type": "Question", "name": "L'hémizygote peut-il causer des anomalies physiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines conditions hémizygotes peuvent entraîner des anomalies physiques visibles." } }, { "@type": "Question", "name": "Y a-t-il des symptômes neurologiques liés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Certaines formes d'hémizygotie peuvent être associées à des troubles neurologiques." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le sexe ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent différer entre les hommes et les femmes en raison de l'hémizygotie." } }, { "@type": "Question", "name": "L'hémizygote est-il lié à des troubles mentaux ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent un lien entre l'hémizygotie et des troubles mentaux spécifiques." } }, { "@type": "Question", "name": "Comment prévenir les maladies liées à l'hémizygotie ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Le dépistage génétique et le conseil génétique sont essentiels pour la prévention." } }, { "@type": "Question", "name": "Le conseil génétique est-il recommandé ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le conseil génétique aide à évaluer les risques et à informer les familles." } }, { "@type": "Question", "name": "Y a-t-il des tests prénataux disponibles ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests prénataux peuvent détecter certaines conditions hémizygotes avant la naissance." } }, { "@type": "Question", "name": "Les vaccinations peuvent-elles aider ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccinations ne préviennent pas l'hémizygotie, mais protègent contre d'autres maladies." } }, { "@type": "Question", "name": "L'éducation génétique est-elle importante ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'éducation génétique aide à comprendre les risques et les implications de l'hémizygotie." } }, { "@type": "Question", "name": "Quels traitements existent pour l'hémizygotie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement dépend de la condition sous-jacente, incluant thérapies géniques ou médicamenteuses." } }, { "@type": "Question", "name": "Peut-on prévenir les effets de l'hémizygotie ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La prévention dépend de la maladie spécifique, avec des options comme le dépistage génétique." } }, { "@type": "Question", "name": "Les traitements sont-ils différents pour les hommes et les femmes ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements peuvent varier en fonction du sexe et de la condition génétique." } }, { "@type": "Question", "name": "Y a-t-il des thérapies spécifiques pour l'hémophilie ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des traitements comme les facteurs de coagulation sont utilisés pour l'hémophilie." } }, { "@type": "Question", "name": "Les thérapies géniques sont-elles efficaces ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les thérapies géniques montrent des résultats prometteurs pour certaines conditions hémizygotes." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec l'hémizygotie ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications varient selon la condition, incluant des troubles de la santé physique et mentale." } }, { "@type": "Question", "name": "L'hémizygotie peut-elle affecter la fertilité ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines conditions hémizygotes peuvent entraîner des problèmes de fertilité." } }, { "@type": "Question", "name": "Y a-t-il des risques de maladies cardiovasculaires ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études montrent un lien entre l'hémizygotie et un risque accru de maladies cardiovasculaires." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Cela dépend de la condition; certaines complications peuvent être gérées, d'autres non." } }, { "@type": "Question", "name": "L'hémizygotie est-elle liée à des cancers ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines formes d'hémizygotie peuvent être associées à un risque accru de certains cancers." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de l'hémizygotie ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux et des mutations génétiques spécifiques." } }, { "@type": "Question", "name": "L'âge parental influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'âge avancé des parents peut augmenter le risque de mutations génétiques." } }, { "@type": "Question", "name": "Les facteurs environnementaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains facteurs environnementaux peuvent interagir avec la génétique et augmenter le risque." } }, { "@type": "Question", "name": "Y a-t-il des prédispositions raciales ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certaines populations peuvent avoir des prédispositions génétiques spécifiques à l'hémizygotie." } }, { "@type": "Question", "name": "Les habitudes de vie influencent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des habitudes de vie comme le tabagisme peuvent interagir avec des facteurs génétiques." } } ] } ] }

Sources (2077 au total)

Unraveling Shared and Unique Genetic Causal Relationship Between Gut Microbiota and Four Types of Uterine-Related Diseases: Bidirectional Mendelian Inheritance Approaches to Dissect the "Gut-Uterus Axis".

The gut microbiota has emerged as a pivotal factor in the etiology of uterine-related diseases. This study aims to elucidate the genetic causal link between gut microbiota composition and these condit... We utilized pooled data from two different GWAS databases, including data from 209 gut microbiota traits and data from four uterus-related diseases. Bidirectional Mendelian Randomization (MR) approach... Seventeen significant associations were identified between gut microbiota traits and uterine-related diseases, suggesting potential causal links. These associations were consistent across sensitivity ... This research establishes a causal relationship between gut microbiota and uterine diseases, advocating for targeted interventions to mitigate associated risks. It underscores the interconnectedness o...

γ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS).

Genetic variants that cause autosomal dominant Alzheimer's disease are highly penetrant but vary substantially regarding age at symptom onset (AAO), rates of cognitive decline, and biomarker changes. ... For this cross-sectional and longitudinal analysis, we used data from participants enrolled in the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS) via the DIAN-OBS data freeze ve... Data were included from 190 people carrying PSEN1 pathogenic variants, among whom median age was 39·0 years (IQR 32·0 to 48·0) and AAO was 44·5 years (40·6 to 51·4). 109 (57%) of 190 carriers were fem... Our findings suggest that clinical heterogeneity in people with autosomal dominant Alzheimer's disease can be at least partly explained by different effects of PSEN1 variants on γ-secretase activity a... US National Institute on Aging, Alzheimer's Association, German Center for Neurodegenerative Diseases, Raul Carrea Institute for Neurological Research, Japan Agency for Medical Research and Developmen...

Generation of two mother-child pairs of iPSCs from maternally inherited Leigh syndrome patients with m.8993 T > G and m.9176 T > G MT-ATP6 mutations.

We generated two pairs of mother-child iPSCs lines for Maternally Inherited Leigh Syndrome (MILS) carrying the m.8993 T > G and m.9176 T > G mutations in the MT-ATP6 gene. We delivered reprogramming f...

Higher systolic blood pressure in early-mid adulthood is associated with poorer cognitive performance in those with a dominantly inherited Alzheimer's disease mutation but not in non-carriers. Results from the DIAN study.

The Dominantly Inherited Alzheimer Network (DIAN) is a longitudinal observational study that collects data on cognition, blood pressure (BP), and other variables from autosomal-dominant Alzheimer's di... We examined cross-sectional and longitudinal relationships between systolic and diastolic BP and cognition in DIAN MC and NC.... Data were available from 528 participants, who had a mean age of 38 (SD = 11) and were 42% male and 61% MCs, at a median follow-up of 2 years. Linear-multilevel models found only cross-sectional assoc... Higher systolic BP was cross-sectionally but not longitudinally associated with poorer cognition, particularly in MCs. BP may influence cognition gradually, but further longitudinal research is needed...

Association of laboratory test results with the bleeding history in patients with inherited platelet function disorders (the Bleeding Assesment Tool - LABoratory tests substudy): communication from the Platelet Physiology ISTH-SSC.

In hemophilia and von Willebrand disease, the degree of alteration of laboratory assays correlates with bleeding manifestations. Few studies have assessed the predictive value for bleeding of laborato... To assess whether there is an association between platelet function assay results and bleeding history, as evaluated by the International Society on Thrombosis and Haemostasis (ISTH) bleeding assessme... Centers participating in the international ISTH-BAT validation study were asked to provide results of the diagnostic assays employed for the patients they enrolled, and the association with the indivi... Sixty-eight patients with 14 different IPFDs were included. Maximal amplitude of platelet aggregation was significantly lower in patients with a pathologic BS and correlated inversely with the BS, a f... This study shows that altered platelet laboratory assay results are associated with an abnormal ISTH-BAT BS in IPFD....

Next generation sequencing (NGS) interest in deciphering erythrocyte molecular defects' association in red cell disorders: Clinical and erythrocyte phenotypes of patients with mutations inheritance in PIEZO1, Spectrin ß1, RhAG and SLC4A1.

We report here an instructive case referred at 16 months-old for exploration of hemolysis without anemia (compensated anemia with reticulocytosis). The biology tests confirmed the hemolysis with incre...